Real-world comparison of anti-CD20 therapies: efficacy, infections, and immune profiles in a German cohort

BackgroundThe use of anti-CD20 drugs has become a widespread therapeutic approach in systemic and central nervous system (CNS) neuroinflammation. Apart from the desired B-cell depletion, relevant dynamics of the humoral and cellular immune response occur. Despite the extensive utilization of these d...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Jakob Stögbauer, Moritz Bewarder, Linda Groß, Lorenz Thurner, Klaus Fassbender, Rebecca Urschel, Einar A. Høgestøl, Gro O. Nygaard, Hanne F. Harbo, Olaf Stüve, Marc Pawlitzki, Sven G. Meuth, Martina Sester, Sergiu Groppa, Mathias Fousse
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2026-05-01
Edice:	Frontiers in Immunology
Témata:	B-cell depletion cellular immune status multiple sclerosis neuroimmunological diseases ocrelizumab ofatumumab
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1738865/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!